Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | ZNF346 | Human | (-)-alpha-phellandrene | decreases expression | EXP | | 6480464 | alpha phellandrene results in decreased expression of ZFP346 mRNA | CTD | PMID:25075043 | ZNF346 | Human | 17beta-estradiol | decreases expression | ISO | Zfp346 (Rattus norvegicus) | 6480464 | Estradiol results in decreased expression of ZFP346 mRNA | CTD | PMID:32145629 | ZNF346 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Zfp346 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ZFP346 mRNA | CTD | PMID:21570461 | ZNF346 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Zfp346 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ZFP346 mRNA | CTD | PMID:33387578 | ZNF346 | Human | 3,3',5,5'-tetrabromobisphenol A | increases expression | ISO | Zfp346 (Rattus norvegicus) | 6480464 | tetrabromobisphenol A results in increased expression of ZNF346 mRNA | CTD | PMID:27914987 | ZNF346 | Human | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Zfp346 (Mus musculus) | 6480464 | N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of ZFP346 mRNA | CTD | PMID:26251327 | ZNF346 | Human | aflatoxin B1 | increases expression | ISO | Zfp346 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of ZFP346 mRNA | CTD | PMID:19770486 | ZNF346 | Human | alpha-phellandrene | decreases expression | EXP | | 6480464 | alpha phellandrene results in decreased expression of ZFP346 mRNA | CTD | PMID:25075043 | ZNF346 | Human | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of ZNF346 mRNA | CTD | PMID:24449571 | ZNF346 | Human | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of ZNF346 mRNA | CTD | PMID:33212167 | ZNF346 | Human | arsane | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of ZNF346 gene | CTD | PMID:25304211 | ZNF346 | Human | arsenic atom | affects methylation | EXP | | 6480464 | Arsenic affects the methylation of ZNF346 gene | CTD | PMID:25304211 | ZNF346 | Human | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of ZNF346 mRNA | CTD | PMID:22378314 | ZNF346 | Human | benzo[a]pyrene | increases expression | ISO | Zfp346 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of ZFP346 mRNA | CTD | PMID:22228805 | ZNF346 | Human | benzo[a]pyrene | multiple interactions | ISO | Zfp346 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ZFP346 mRNA | CTD | PMID:27858113 | ZNF346 | Human | benzo[b]fluoranthene | multiple interactions | ISO | Zfp346 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ZFP346 mRNA | CTD | PMID:27858113 | ZNF346 | Human | bisphenol A | affects expression | ISO | Zfp346 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of ZNF346 mRNA | CTD | PMID:25181051 | ZNF346 | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of ZNF346 gene | CTD | PMID:31601247 | ZNF346 | Human | bisphenol A | increases expression | ISO | Zfp346 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of ZFP346 mRNA | CTD | PMID:34947998 | ZNF346 | Human | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ZNF346 mRNA | CTD | PMID:29275510 | ZNF346 | Human | cadmium dichloride | decreases methylation | ISO | Zfp346 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in decreased methylation of ZFP346 promoter | CTD | PMID:22457795 | ZNF346 | Human | cannabidiol | decreases expression | EXP | | 6480464 | Cannabidiol results in decreased expression of ZNF346 mRNA | CTD | PMID:33244087 | ZNF346 | Human | carbon nanotube | decreases expression | ISO | Zfp346 (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of ZFP346 mRNA | CTD | PMID:25554681 | ZNF346 | Human | chloroprene | decreases expression | ISO | Zfp346 (Mus musculus) | 6480464 | Chloroprene results in decreased expression of ZFP346 mRNA | CTD | PMID:23125180 | ZNF346 | Human | choline | multiple interactions | ISO | Zfp346 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZFP346 gene | CTD | PMID:20938992 | ZNF346 | Human | chrysene | multiple interactions | ISO | Zfp346 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ZFP346 mRNA | CTD | PMID:27858113 | ZNF346 | Human | dibutyl phthalate | decreases expression | ISO | Zfp346 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of ZFP346 mRNA | CTD | PMID:21266533 | ZNF346 | Human | diclofenac | decreases expression | ISO | Zfp346 (Mus musculus) | 6480464 | Diclofenac results in decreased expression of ZFP346 mRNA | CTD | PMID:35537566 | ZNF346 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF346 mRNA | CTD | PMID:27188386 | ZNF346 | Human | enzyme inhibitor | multiple interactions | EXP | | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ZNF346 protein | CTD | PMID:23301498 | ZNF346 | Human | folic acid | multiple interactions | ISO | Zfp346 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZFP346 gene | CTD | PMID:20938992 | ZNF346 | Human | folic acid | decreases expression | ISO | Zfp346 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of ZFP346 mRNA | CTD | PMID:25629700 | ZNF346 | Human | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of ZNF346 gene | CTD | PMID:31601247 | ZNF346 | Human | gentamycin | increases expression | ISO | Zfp346 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of ZFP346 mRNA | CTD | PMID:33387578 | ZNF346 | Human | inulin | multiple interactions | ISO | Zfp346 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ZFP346 mRNA | CTD | PMID:36331819 | ZNF346 | Human | isoprenaline | increases expression | ISO | Zfp346 (Mus musculus) | 6480464 | Isoproterenol results in increased expression of ZFP346 mRNA | CTD | PMID:20003209 | ZNF346 | Human | ivermectin | decreases expression | EXP | | 6480464 | Ivermectin results in decreased expression of ZNF346 protein | CTD | PMID:32959892 | ZNF346 | Human | L-methionine | multiple interactions | ISO | Zfp346 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of ZFP346 gene | CTD | PMID:20938992 | ZNF346 | Human | maneb | multiple interactions | ISO | Zfp346 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of ZFP346 mRNA | CTD | PMID:36117858 | ZNF346 | Human | ozone | multiple interactions | ISO | Zfp346 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ZFP346 mRNA | CTD | PMID:34911549 | ZNF346 | Human | paracetamol | increases expression | ISO | Zfp346 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of ZFP346 mRNA | CTD | PMID:33387578 | ZNF346 | Human | paraquat | multiple interactions | ISO | Zfp346 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of ZFP346 mRNA | CTD | PMID:36117858 | ZNF346 | Human | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Zfp346 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of ZFP346 mRNA | CTD | PMID:36331819 | ZNF346 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF346 mRNA | CTD | PMID:27188386 | ZNF346 | Human | Soman | decreases expression | ISO | Zfp346 (Rattus norvegicus) | 6480464 | Soman results in decreased expression of ZFP346 mRNA | CTD | PMID:19281266 | ZNF346 | Human | T-2 toxin | increases expression | EXP | | 6480464 | T-2 Toxin results in increased expression of ZNF346 mRNA | CTD | PMID:34581912 | ZNF346 | Human | tetraphene | increases expression | ISO | Zfp346 (Mus musculus) | 6480464 | benz(a)anthracene results in increased expression of ZFP346 mRNA | CTD | PMID:26377693 | ZNF346 | Human | tetraphene | multiple interactions | ISO | Zfp346 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of ZFP346 mRNA | CTD | PMID:27858113 | ZNF346 | Human | titanium dioxide | increases expression | ISO | Zfp346 (Mus musculus) | 6480464 | titanium dioxide analog results in increased expression of ZFP346 mRNA | CTD | PMID:25111187 | ZNF346 | Human | triptonide | affects expression | ISO | Zfp346 (Mus musculus) | 6480464 | triptonide affects the expression of ZFP346 mRNA | CTD | PMID:33045310 | ZNF346 | Human | trovafloxacin | decreases expression | ISO | Zfp346 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of ZFP346 mRNA | CTD | PMID:35537566 | ZNF346 | Human | valproic acid | affects expression | ISO | Zfp346 (Mus musculus) | 6480464 | Valproic Acid affects the expression of ZFP346 mRNA | CTD | PMID:17292431 | ZNF346 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF346 mRNA | CTD | PMID:27188386 | ZNF346 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of ZNF346 mRNA | CTD | PMID:23179753 more ... | ZNF346 | Human | vinclozolin | increases expression | ISO | Zfp346 (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of ZFP346 mRNA | CTD | PMID:20566332 | |